Quintiles Transnational and its owners plan to raise up to $788M in an NYSE IPO that will give...
Quintiles Transnational and its owners plan to raise up to $788M in an NYSE IPO that will give the pharmaceuticals testing company a market cap of around $4.9B at the mid-point of a projected price range of $36-40 a share. Quintiles intends to sell 13.8M, while its shareholders, which include TPG and Bain, plan to offer 5.9M shares. Quintiles will trade under the ticker symbol Q. (previous)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs